Optimal delivery of aerosolized medication to mechanically ventilated pediatric and neonatal patients: A scoping review

被引:0
|
作者
Chartrand, Louise [1 ]
Ploszay, Victoria [2 ]
Tessier, Sebastien [3 ]
机构
[1] Univ Manitoba, Dept Resp Therapy, Winnipeg, MB, Canada
[2] St Boniface Gen Hosp, Winnipeg, MB, Canada
[3] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada
来源
CANADIAN JOURNAL OF RESPIRATORY THERAPY | 2022年 / 58卷 / 01期
关键词
aerosol therapy; mechanical ventilation; pediatric; scoping review; optimization of medication delivery; METERED-DOSE INHALER; NEBULIZER TYPE; POSITION; THERAPY; SPACER;
D O I
10.29390/cjrt-2022-044
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Delivering aerosolized medication to patients during mechanical ventilation is a common practice in respiratory therapy for adult, pediatric, and neonatal populations. However, aerosol delivery in pediatric populations is inconsistent and challenging, impacting how the drug is delivered. Some factors that influence drug delivery efficiency are directly under the purview of the clinician or therapist administering the drugs. However, excessive variability exists amongst clinicians and therapists working at the same site and between different sites. This review aims to systematically summarize the literature to identify current practice variations, identify common practices, and provide suggestions to guide future research in this area. In addition, this scoping review aims to identify the available evidence and knowledge gaps in the literature regarding the delivery of aerosolized medication to pediatric populations during mechanical ventilation. More specifically, the question that guided our research was: What are the best strategies for optimizing aerosol delivery of medication to pediatric patients, including neonates, while on mechanical ventilation?Methods: A scoping review, using the Joanna Briggs Institute methodology, was conducted until September 2022 in the CINAHL, EMBASE (Ovid), and Medline (Ovid) databases. Our initial search yielded 248 articles. After screening the titles, abstracts, and full text of the articles according to inclusion and exclusion criteria, five articles were analyzed.Results: We identified three main topics for discussion: the type of device used for administering aerosolized medication, appropriate mechanical ventilation settings, and optimal placement of the nebulizer delivery system.Conclusion: Of the three topics we intended to discuss, we only found enough evidence to suggest using mesh nebulizers to increase aerosol deposition. We found conflicting or outdated results for the other two topics. This demonstrates a significant gap in the literature since aerosol medications are rou-tinely administered to mechanically ventilated neonatal and other pediatric patients.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [21] Variation in enteral nutrition delivery in mechanically ventilated patients
    Rice, TW
    Swope, T
    Bozeman, S
    Wheeler, AP
    NUTRITION, 2005, 21 (7-8) : 786 - 792
  • [22] ASSOCIATION OF FEVER AND ANTIPYRETIC MEDICATION WITH OUTCOMES IN MECHANICALLY VENTILATED PATIENTS
    Drewry, Anne M.
    Evans, Emily M.
    Doctor, Rebecca J.
    Gage, Brian F.
    Hotchkiss, Richard S.
    Fuller, Brian M.
    SHOCK, 2019, 51 (06): : 142 - 143
  • [23] Non invasive monitoring in mechanically ventilated pediatric patients
    Al-Subu, Awni M.
    Rehder, Kyle J.
    Cheifetz, Ira M.
    Turner, David A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (06) : 693 - 702
  • [24] Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
    Luyt, Charles-Edouard
    Clavel, Marc
    Guntupalli, Kalpalatha
    Johannigman, Jay
    Kennedy, John I.
    Wood, Christopher
    Corkery, Kevin
    Gribben, Dennis
    Chastre, Jean
    CRITICAL CARE, 2009, 13 (06)
  • [25] Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
    Charles-Edouard Luyt
    Marc Clavel
    Kalpalatha Guntupalli
    Jay Johannigman
    John I Kennedy
    Christopher Wood
    Kevin Corkery
    Dennis Gribben
    Jean Chastre
    Critical Care, 13
  • [26] Augmentative and Alternative Communication Interventions in Critical and Acute Care With Mechanically Ventilated and Tracheostomy Patients: A Scoping Review
    LaValley, Mimi
    Chavers-Edgar, Tiffany
    Wu, Mengxuan
    Schlosser, Ralf
    Koul, Rajinder
    AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2024, 33 (05) : 2667 - 2686
  • [27] Flow trigger setting in mechanically ventilated neonates, children and adults: a scoping review
    Robert G. T. Blokpoel
    A. A. Koopman
    Martin C. J. Kneyber
    Intensive Care Medicine – Paediatric and Neonatal, 2 (1):
  • [28] AEROSOL DEPOSITION IN MECHANICALLY VENTILATED PATIENTS - OPTIMIZING NEBULIZER DELIVERY
    ORIORDAN, TG
    PALMER, L
    SMALDONE, GC
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A895 - A895
  • [29] MEDICATION USE EVALUATION OF KETAMINE FOR SEDATION AND ANALGESIA IN MECHANICALLY VENTILATED PATIENTS
    Daniell, Jessica
    Cheung, Cynthia
    McGill, Bryan
    Ahearn, Paul
    Albano, Jesse
    Ammar, Mahmoud
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 546 - 546
  • [30] EFFECT OF DORNASE ALPHA ADMINISTRATION IN MECHANICALLY VENTILATED PEDIATRIC PATIENTS
    Ngo, Larry
    Martinez, Juan
    Dehom, Salem
    Thomas, Sharon
    Shimabukuro, Kozue
    CRITICAL CARE MEDICINE, 2015, 43 (12)